24 results on '"Nijkamp, Wouter"'
Search Results
2. Supplementary Table 2 from Phosphatidylinositol 3-Kinase Hyperactivation Results in Lapatinib Resistance that Is Reversed by the mTOR/Phosphatidylinositol 3-Kinase Inhibitor NVP-BEZ235
3. Supplementary Table 1 from Phosphatidylinositol 3-Kinase Hyperactivation Results in Lapatinib Resistance that Is Reversed by the mTOR/Phosphatidylinositol 3-Kinase Inhibitor NVP-BEZ235
4. Data from Phosphatidylinositol 3-Kinase Hyperactivation Results in Lapatinib Resistance that Is Reversed by the mTOR/Phosphatidylinositol 3-Kinase Inhibitor NVP-BEZ235
5. Supplementary Figure 1 from Phosphatidylinositol 3-Kinase Hyperactivation Results in Lapatinib Resistance that Is Reversed by the mTOR/Phosphatidylinositol 3-Kinase Inhibitor NVP-BEZ235
6. Supplementary Figure 3 from Phosphatidylinositol 3-Kinase Hyperactivation Results in Lapatinib Resistance that Is Reversed by the mTOR/Phosphatidylinositol 3-Kinase Inhibitor NVP-BEZ235
7. Supplementary Figure 2 from Phosphatidylinositol 3-Kinase Hyperactivation Results in Lapatinib Resistance that Is Reversed by the mTOR/Phosphatidylinositol 3-Kinase Inhibitor NVP-BEZ235
8. ZNF423 Is Critically Required for Retinoic Acid-Induced Differentiation and Is a Marker of Neuroblastoma Outcome
9. A large-scale RNAi screen in human cells identifies new components of the p53 pathway
10. Loss of ARID1A activates ANXA1, which serves as a predictive biomarker for trastuzumab resistance
11. Loss of ARID1A activates ANXA1, which serves as a predictive biomarker for trastuzumab resistance
12. Loss of ARID1A Activates ANXA1, which Serves as a Predictive Biomarker for Trastuzumab Resistance
13. SMARCE1 suppresses EGFR expression and controls responses to MET and ALK inhibitors in lung cancer
14. SMARCE1 suppresses EGFR expression and controls responses to MET and ALK inhibitors in lung cancer
15. Abstract LB-240: SMARCE1 suppresses EGFR expression and controls responses to MET and ALK inhibitors in lung cancer
16. SMARCE1 suppresses EGFR expression and controls responses to MET and ALK inhibitors in lung cancer
17. The Corepressor CTBP2 Is a Coactivator of Retinoic Acid Receptor/Retinoid X Receptor in Retinoic Acid Signaling
18. MED12 Controls the Response to Multiple Cancer Drugs through Regulation of TGF-β Receptor Signaling
19. A genome-wide RNAi screen in mouse embryonic stem cells identifies Mp1 as a key mediator of differentiation
20. NF1 Is a Tumor Suppressor in Neuroblastoma that Determines Retinoic Acid Response and Disease Outcome
21. Abstract A30: NF1 is a tumor suppressor in neuroblastoma that determines retinoic acid response and disease outcome
22. Phosphatidylinositol 3-Kinase Hyperactivation Results in Lapatinib Resistance that Is Reversed by the mTOR/Phosphatidylinositol 3-Kinase Inhibitor NVP-BEZ235
23. Telomerase-independent Regulation of ATR by Human Telomerase RNA
24. A genome-wide RNAi screen in mouse embryonic stem cells identifies Mp1 as a key mediator of differentiation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.